US Activist Hedge Fund Institutional SEC 13D 13G — July 21, 2026

Activist & Institutional Activity

By Gunpowder Editorial ·

12 high priority 17 medium priority 29 total filings analysed

Executive Summary

The 29 filings for July 21, 2026, reveal a landscape dominated by corporate control events and significant insider ownership adjustments. The most material developments are the take-private of KORE Group Holdings at $9.25/share and the announced acquisition of Personalis by Tempus AI, both high-certainty catalysts. A notable cluster of insider activity is seen at ZeroStack Corp.

(formerly Flora Growth), where three insiders—including the CEO—collectively control over 70% of shares and are incentivized by aggressive performance-based options tied to VWAP targets up to $17.85, a 250% premium to the exercise price. Passive institutional investors like Millennium Management and Royce & Associates are making measured, diversified bets, while a few filers (e.g., Dror Sherman at iPower) show rapid, opportunistic trading. The data suggests a bifurcated market: high-conviction insider moves in small/mid-cap names versus passive accumulation in larger, liquid names. No sector-wide margin or revenue trends are discernible from this set of filings, as they are primarily ownership disclosures rather than operating reports.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Schedule 13D · Schedule 13G

Tracking the trend? Catch up on the prior US Activist Hedge Fund Institutional SEC 13D 13G digest from July 20, 2026.

Investment Signals (11)

  • Tempus AI / Personalis (BULLISH)

    Merger agreement signed July 20, 2026, for Tempus to acquire Personalis. Tempus already holds 12.5% of shares. This is a high-conviction, near-term catalyst with a defined deal structure.

  • Take-private completed on July 21, 2026, at $9.25/share cash. All ABRY-related holders now have zero ownership. This is a closed event with a guaranteed payout for remaining shareholders.

  • ZeroStack Corp. (CEO Daniel Reis-Faria) (BULLISH)

    CEO exercised pre-funded warrants into 5.95M shares at $0.0001/share on July 20, 2026, and received 500,000 performance options with VWAP targets up to $17.85. This signals extreme insider confidence and a clear roadmap for value creation.

  • ZeroStack Corp. (Chairman Michael Heinrich) (BULLISH)

    Chairman and 0G entity hold 30.2% of shares. Combined with CEO's 37.5% stake, insider ownership exceeds 70%, creating strong alignment with minority shareholders.

  • Butterfly Network (Founder Jonathan Rothberg)

    Sold 3.13M shares (~$20M) over July 17-21 under a pre-arranged 10b5-1 plan for estate planning. While not a bearish signal, the consistent selling pressure over five days is a short-term overhang. [NEUTRAL/BEARISH]

  • Lumina Capital disclosed an 18.96% passive stake as of June 30, 2026. This is a large, concentrated position in a small-cap bank, suggesting deep fundamental conviction.

  • A single filer disclosed a 30.64% passive stake, a massive position that implies significant influence and alignment, despite the passive filing designation.

  • Royce & Associates increased its stake to 7.81% as of June 30, 2026, up from a prior undisclosed level. This is a vote of confidence from a seasoned small-cap value manager.

  • QumulusAI (Robert Bissell) (NEUTRAL)

    A 17.8% insider stake was disclosed, with shares held through multiple entities. This concentrated ownership suggests founder/insider conviction, but the complex structure warrants monitoring.

  • A rapid flip: Sherman acquired 100,000 shares (5.3%) on July 14, then disposed of 90,037, leaving only 0.5%. This is a classic 'hit-and-run' trade, signaling no long-term conviction.

  • Vor Biopharma (RA Capital) (NEUTRAL)

    RA Capital exercised pre-funded warrants on July 16, 2026, increasing its stake to 19.9%, but is blocked from exceeding that threshold. The simultaneous resignation of their board representative (Andrew Levin) on July 6 is a puzzling signal that warrants attention.

Risk Flags (8)

  • Founder Rothberg sold ~$20M in stock over five consecutive days. While under a 10b5-1 plan, the concentrated selling creates a persistent overhang on the stock.

  • Dror Sherman went from a 5.3% holder to 0.5% in one week. This suggests a lack of confidence and could spook other investors.

  • Andrew Levin (RA Capital partner) resigned from the board on July 6, just days before RA Capital exercised warrants. The timing and lack of explanation create governance uncertainty.

  • The stock is now delisted and deregistered. Shareholders who did not tender face a potentially illiquid and uncertain path to receiving the $9.25 cash consideration.

  • ZeroStack Corp / Concentrated Ownership [MEDIUM RISK]

    With over 70% of shares held by three insiders, the stock is extremely illiquid and susceptible to price manipulation or sudden insider sales.

  • A single trust (John Hancock Stable Value Fund) holds 25% of the fund. A redemption by this holder could force a fire sale of assets.

  • The sponsor holds 17% of shares at a cost basis of ~$0.02/share for Class B shares. This creates a massive incentive to close any deal, potentially at the expense of public shareholders.

  • Stonepine Capital holds warrants for 6M shares, exercisable subject to a 9.99% blocker. If the stock appreciates, dilution from these warrants could cap upside.

Opportunities (8)

  • Tempus AI announced a merger on July 20. The deal spread (if any) provides a near-term, low-risk arbitrage opportunity. The 12.5% pre-deal stake by Tempus suggests a high probability of completion.

  • ZeroStack Corp / Performance Option Catalyst (OPPORTUNITY)

    The CEO and another insider have options vesting at VWAP targets from $7.65 to $17.85 (current price ~$5.10). This creates a powerful incentive to drive the stock price up by 50-250%.

  • Shareholders who have not yet tendered should do so immediately to receive the $9.25 cash consideration. This is a risk-free arbitrage if the process is still open.

  • A small-cap bank with an 18.96% passive stake from a dedicated fund. This suggests a potential value unlock or activist lite scenario.

  • Royce, a respected small-cap manager, increased its stake to 7.81%. This is a strong signal that the stock is undervalued.

  • A single filer owns 30.64%. This extreme concentration often precedes a take-private or major strategic move.

  • Impax, a sustainability-focused asset manager, disclosed a 5.41% stake. This could signal a long-term, patient investor base.

  • Millennium's 3.6% stake is a small but notable position in a high-growth restaurant chain. This could be a catalyst for further institutional interest.

Sector Themes (5)

  • Small-Cap Insider Concentration

    Multiple filings (ZeroStack, RYVYL, QumulusAI) show insiders holding 17-37% of shares. This pattern suggests founders/insiders are betting big on their own companies, creating high alignment but also liquidity risk.

  • Passive Institutional Accumulation

    Firms like Millennium Management, Royce & Associates, and Impax Asset Management are filing 13Gs for small/mid-cap positions (3-8% stakes). This indicates a 'risk-on' rotation into smaller names by institutional investors.

  • SPAC Sponsor Economics

    The Research Alliance Corp IV filing highlights the extreme asymmetry in SPACs: sponsors pay $0.02/share for founder shares while public shareholders pay $10.00. This misalignment is a recurring risk in the SPAC space.

  • Take-Private and M&A Wave

    The KORE take-private and Tempus/Personalis merger in a single day's filings suggest an active M&A environment, particularly for companies with depressed valuations or strategic value.

  • Performance-Based Incentive Structures

    ZeroStack Corp's options tied to escalating VWAP targets (from $7.65 to $17.85) represent a modern, aggressive compensation structure that directly links management pay to stock price appreciation.

Watch List (8)

  • Watch for shareholder vote and regulatory approvals. The deal is expected to close in late 2026. Monitor for any competing bids.

  • ZeroStack Corp / VWAP Targets
    👁

    Monitor the stock price for progress toward the $7.65 VWAP threshold for the first option tranche. Insider buying/selling around these levels will be key.

  • Watch for any further sales by Rothberg. If he continues selling beyond the 10b5-1 plan, it would be a significant bearish signal.

  • Monitor for any further board changes or public statements from RA Capital regarding their strategy, especially given the recent resignation.

  • Watch for the final distribution of $9.25/share to remaining shareholders and the completion of the deregistration process.

  • Watch for any Schedule 13D filing (activist) or further increases in the stake, which would signal a more active role.

  • Monitor the stock price. If it appreciates significantly, Stonepine Capital may exercise its warrants, leading to dilution.

  • Watch for the announcement of a target company. The sponsor's low cost basis creates a strong incentive to close a deal quickly.

Filing Analyses (29)
StageWise Strategies Corp. SC 13D/A neutral materiality 6/10

21-07-2026

Jakhongir Abidovich Artikkhodjaev, the founder and principal shareholder of Tourism and Entertainment Group, filed a Schedule 13D/A disclosing the purchase of 1,000,000 shares of StageWise Strategies Corp. common stock for $250,000 of personal funds on July 17, 2026. This transaction increased his beneficial ownership from approximately 74.2% to 79.8% of the issuer's outstanding shares, based on 5,044,334 shares outstanding. The filing states no current plans for extraordinary corporate transactions, changes in control, or other major actions.

  • · The purchase was completed on July 17, 2026 (the Closing Date).
  • · The Reporting Person is a citizen of Uzbekistan.
  • · The Reporting Person has not been convicted in any criminal proceedings or been party to adverse securities-related civil proceedings in the last five years.
  • · The Reporting Person may in the future cause the issuer to enter into a transaction involving a future acquisition of a compatible business, but currently has no contracts or arrangements for such a transaction.
  • · The filing incorporates by reference a Share Subscription Agreement dated June 30, 2026, filed as an exhibit to the issuer's Form 8-K on July 7, 2026.
Manchester United plc SC 13G neutral materiality 5/10

21-07-2026

Boldhaven Management LLP disclosed a 5.6% beneficial ownership stake in Manchester United plc's Class A Ordinary Shares as of June 30, 2026, holding 3,113,537 shares. The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not with the intent to influence control. No single client's interest exceeds 5% of the total outstanding shares.

  • · The filing is a Schedule 13G, indicating passive investment intent.
  • · Boldhaven Management LLP is based in London, UK.
  • · The filing date is July 21, 2026, with the beneficial ownership as of June 30, 2026.
Personalis, Inc. SC 13D/A neutral materiality 9/10

21-07-2026

Tempus AI, Inc. disclosed a 12.5% beneficial ownership stake in Personalis, Inc. as of July 19, 2026, following the execution of a merger agreement on July 20, 2026. The filing reports 13,039,067 shares held by Tempus and an additional 150,000 shares held directly by Tempus's controlling stockholder Eric Lefkofsky, bringing the combined beneficial ownership to 13,189,067 shares (12.6%). The merger agreement, dated July 20, 2026, was entered into among Tempus AI, Personalis, Aviary Development, Inc., and Toucan Development, LLC, indicating an acquisition of Personalis by Tempus.

  • · The Schedule 13D/A was filed as Amendment No. 3, originally filed on May 7, 2026.
  • · No transactions in the common stock were effected by the reporting persons during the past 60 days.
  • · The merger agreement is dated July 20, 2026, and was incorporated by reference to Personalis's Form 8-K filed on the same date.
KORE Group Holdings, Inc. SC 13D/A neutral materiality 9/10

21-07-2026

On July 21, 2026, KORE Group Holdings, Inc. was taken private via a merger, with shareholders receiving $9.25 per share in cash. All ABRY-related reporting persons, who previously held shares, contributed their stock to the parent entity and now hold no beneficial ownership of the surviving corporation's common stock. The common stock was suspended from trading on the NYSE and a Form 25 has been filed to delist and deregister the shares.

  • · The merger was consummated on July 21, 2026, with KORE Group Holdings as the surviving corporation.
  • · ABRY entities contributed their shares to the parent immediately prior to the merger in exchange for interests in the parent.
  • · All reporting persons (ABRY funds and individuals) now hold 0 shares and 0% beneficial ownership of the surviving corporation.
  • · The common stock was suspended from trading on the NYSE before the opening on July 21, 2026.
  • · NYSE filed a Form 25 to delist and deregister the common stock under Section 12(b) of the Exchange Act.
KORE Group Holdings, Inc. SC 13D/A neutral materiality 5/10

21-07-2026

Searchlight IV KOR, L.P. filed Amendment No. 10 to its Schedule 13D for KORE Group Holdings, Inc. on July 21, 2026, reporting continued beneficial ownership of common stock. The filing incorporates numerous exhibits related to investment agreements, warrants, and a merger agreement dated February 26, 2026, indicating ongoing strategic involvement by Searchlight and related parties in KORE's corporate transactions.

  • · Amendment No. 10 to Schedule 13D was filed on July 21, 2026.
  • · The filing incorporates an Agreement and Plan of Merger dated February 26, 2026, between KORE, KONA Parent L.P., and KONA Merger Sub Co.
  • · Multiple Rollover, Voting and Support Agreements were entered into with various parties including Dotmar Investments Limited, Richard Burston, and Terrdian Holdings Inc. on March 17, 2026.
  • · Searchlight IV KOR, L.P. reported 0 shares of common stock beneficially owned, with the filing referencing prior agreements and transactions.
Research Alliance Corp IV SC 13G neutral materiality 3/10

21-07-2026

Trails Edge Capital Partners, LP and related entities disclosed beneficial ownership of 500,000 Class A Ordinary Shares of Research Alliance Corp IV, representing 5.5% of outstanding shares as of July 14, 2026. The filing is a routine Schedule 13G by an investment manager and its affiliates, indicating passive investment intent. No changes in ownership or performance metrics are reported.

  • · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
  • · The filers certify the securities were not acquired for the purpose of changing or influencing control of the issuer.
  • · A Joint Filing Agreement was executed on July 21, 2026, among the filers.
AEON Biopharma, Inc. SC 13G neutral materiality 5/10

21-07-2026

Stonepine Capital Management, LLC and related entities filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 6,892,682 shares of AEON Biopharma, Inc. Class A Common Stock, representing 9.9% of the outstanding shares. The holdings consist of 3,000,000 shares of Common Stock and warrants to acquire 6,000,000 shares, subject to a 9.99% beneficial ownership limitation. The filing indicates a passive investment intent, with no aim to change or influence control of the issuer.

  • · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment.
  • · The beneficial ownership limitation is set at 9.99%.
  • · The reporting persons disclaim membership in a group and beneficial ownership except for pecuniary interest.
  • · The filing includes a joint filing agreement dated October 10, 2024.
QumulusAI, Inc. SC 13G neutral materiality 6/10

21-07-2026

Robert C. Bissell filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 5,858,484 shares of QumulusAI, Inc. (QMLS) common stock, representing 17.8% of the 32,867,931 shares outstanding. The filing indicates Bissell's holdings are split between shares held directly (1,439,656), through Chalin, Inc. (316,919), and through Gratus Holdings, LLC (4,101,909), with sole voting and dispositive power over the Chalin shares and shared power with his spouse over the Gratus shares.

  • · The filing is made under Rule 13d-1(d) of the Securities Exchange Act of 1934.
  • · Bissell's direct holdings consist of 1,439,656 shares of common stock.
  • · 316,919 shares are held by Chalin, Inc., over which Bissell has sole voting and dispositive power.
  • · 4,101,909 shares are held by Gratus Holdings, LLC, with shared voting and dispositive power between Bissell and his spouse.
  • · The total outstanding shares figure (32,867,931) is based on the Issuer's Prospectus filed July 14, 2026 under Rule 424(b)(4).
GXO Logistics, Inc. SC 13G neutral materiality 5/10

21-07-2026

Spruce House Investment Management LLC and related entities disclosed a 5.2% beneficial ownership stake in GXO Logistics, Inc., holding 6,003,988 shares of common stock as of July 14, 2026. The filing is a Schedule 13G, indicating a passive investment intent, and the shares are held directly by The Spruce House Partnership LLC. No prior period comparison is available as this is an initial filing.

  • · The filing is made under Rule 13d-1(c), confirming a passive investment intent.
  • · Spruce House entities disclaim beneficial ownership except for pecuniary interest.
  • · All 6,003,988 shares are held directly by The Spruce House Partnership LLC.
  • · Zachary Sternberg and Benjamin Stein are deemed to share voting and dispositive power over the shares.
Flora Growth Corp. SC 13D/A neutral materiality 5/10

21-07-2026

Dany Vaiman filed a Schedule 13D/A with the SEC on July 21, 2026, disclosing beneficial ownership of 513,249 common shares of ZeroStack Corp. (formerly Flora Growth Corp.), representing 2.9% of the 17,489,828 outstanding shares on a partially-diluted basis. The filing also reports that on July 20, 2026, shareholders approved a grant of 250,000 stock options to Vaiman (the May 2026 Option Grant), which vest in five tranches contingent on the company's stock achieving escalating VWAP targets from $7.65 to $17.85.

  • · The options have an exercise price of $5.10 per share and vest in five equal installments based on VWAP thresholds: 20% at $7.65, 20% at $10.20, 20% at $12.75, 20% at $15.30, and 20% at $17.85.
  • · Vaiman has sole voting and dispositive power over all 513,249 shares.
  • · The reporting person has not been convicted in any criminal proceeding or been party to any securities-related civil proceeding in the last five years.
Flora Growth Corp. SC 13D/A neutral materiality 6/10

21-07-2026

Michael Heinrich and his wholly-owned entity Zero Gravity Labs Inc. (0G) filed an amended Schedule 13D disclosing a combined beneficial ownership of 5,579,783 common shares of ZeroStack Corp. (formerly Flora Growth Corp.), representing 30.2% of the outstanding shares on a partially-diluted basis. 0G separately holds 4,608,575 shares (26.4% of the class), all of which are shared voting and dispositive authority with Heinrich. The filing reflects no change in Heinrich's position as Chairman of the Board since September 2025 and CEO of 0G.

  • · Heinrich has sole voting and dispositive authority over all 5,579,783 shares; 0G has shared voting and dispositive authority over its 4,608,575 shares.
  • · Heinrich became Chairman of the Board of the Issuer on September 20, 2025.
  • · The filing includes a Joint Filing Agreement dated April 2, 2026, and references a Stock Option Agreement dated May 5, 2026.
  • · Neither Heinrich nor 0G has been convicted in a criminal proceeding or been subject to securities-related civil proceedings in the last five years.
Vor Biopharma Inc. SC 13D/A neutral materiality 5/10

21-07-2026

RA Capital Management, L.P. and its affiliates filed a Schedule 13D/A disclosing that on July 16, 2026, RA Capital Healthcare Fund exercised Pre-Funded Warrants to acquire 2,099,787 shares of Vor Biopharma common stock at $0.002 per share on a cashless basis. The Reporting Persons now beneficially own 12,937,855 shares (19.9% of the outstanding common stock), though the Pre-Funded Warrants contain a blocker preventing exercise above that threshold. Additionally, Andrew Levin resigned from Vor Biopharma's Board of Directors effective July 6, 2026.

  • · The Pre-Funded Warrants contain a beneficial ownership blocker that prevents exercise above 19.99% of outstanding common stock.
  • · The Fund is currently prohibited from exercising Pre-Funded Warrants to exceed 12,937,855 shares due to the blocker.
  • · Andrew Levin resigned from the Board of Directors effective July 6, 2026.
  • · No other transactions in the issuer's securities were effected by the Reporting Persons during the past 60 days.
Research Alliance Corp IV SC 13D neutral materiality 7/10

21-07-2026

Research Alliance Holdings IV LLC and its manager Matthew Hammond filed a Schedule 13D disclosing beneficial ownership of 1,538,529 Class A ordinary shares (including shares issuable upon conversion of Class B shares) of Research Alliance Corp IV, representing 17.0% of the outstanding Class A shares. The filing details the sponsor's investment, including a $25,000 payment for Class B shares and a $2,750,000 private placement of Class A shares at $10.00 per share in connection with the IPO. The reporting persons have agreed to vote in favor of an initial business combination and are subject to lock-up restrictions.

  • · RA Holdings IV acquired 1,014,706 Class B shares for $25,000 ($0.02 per share) on April 7, 2026.
  • · An additional 308,823 Class B shares were issued via share capitalization in June 2026.
  • · RA Holdings IV transferred 30,000 Class B shares to each of John Maslowski and Alan Musso in June 2026.
  • · The Private Placement of 275,000 Class A shares at $10.00 per share closed on July 14, 2026.
  • · Lock-up: Class B shares cannot be transferred until one year after business combination or certain price conditions; Private Placement Shares locked for 30 days after business combination.
  • · Reporting persons have agreed to vote shares in favor of initial business combination and not to redeem shares.
  • · RA Holdings IV has the right to nominate three directors after business combination.
First Watch Restaurant Group, Inc. SC 13G/A neutral materiality 5/10

21-07-2026

Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, reported a 3.4% beneficial ownership stake in First Watch Restaurant Group, Inc. as of June 30, 2026, holding 2,080,302 shares. Millennium Management LLC and related entities collectively own 2,192,811 shares (3.6%), with Israel A. Englander also reporting the same aggregate position. The filing is an amendment to Schedule 13G and certifies the shares were not acquired to influence control of the issuer.

  • · The filing is an amendment to Schedule 13G (SC 13G/A), filed on July 21, 2026, with a date of change of July 21, 2026.
  • · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander.
  • · The filing includes a Joint Filing Agreement dated July 20, 2026, among the reporting persons.
  • · The filing certifies under Rule 13d-1(c) that the securities were not acquired to change or influence control of the issuer.
SOBR Safe, Inc. SC 13G neutral materiality 5/10

21-07-2026

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G disclosing beneficial ownership of 254,445 shares of SOBR Safe, Inc. common stock, representing 5.6% of shares outstanding as of July 21, 2026. The filing also details a July 15, 2026 inducement letter agreement that, absent blocker provisions, would have resulted in deemed beneficial ownership of up to 2,520,713 shares (approximately 9.99% pre-closing) and 1,934,942 shares post-closing. The reported 5.6% stake reflects a reduction from the potential 9.99% due to blocker provisions limiting warrant exercises.

  • · The Schedule 13G is filed pursuant to Rule 13d-1(c), indicating passive investor status.
  • · Intracoastal Capital LLC is a Delaware limited liability company with principal office at 245 Palm Trail, Delray Beach, FL 33483.
  • · Mitchell P. Kopin and Daniel B. Asher each disclaim beneficial ownership of the shares except to the extent of their pecuniary interest.
  • · The filing includes a Joint Filing Agreement among the Reporting Persons.
  • · The inducement letter transaction involved the issuance of 1,082,000 shares at closing, including 318,000 shares to Intracoastal upon exercise of Existing Warrants.
Flora Growth Corp. SC 13D/A neutral materiality 7/10

21-07-2026

Daniel Reis-Faria, CEO of ZeroStack Corp. (formerly Flora Growth Corp.), filed a Schedule 13D/A disclosing beneficial ownership of 6,925,951 common shares, representing 37.5% of the issuer's outstanding shares on a partially-diluted basis. On July 20, 2026, he exercised pre-funded warrants into 5,954,743 common shares at $0.0001 per share, and shareholders approved a grant of 500,000 options with performance-based vesting tied to VWAP targets ranging from $7.65 to $17.85.

  • · The Reporting Person has sole dispositive and voting authority over all 6,925,951 shares.
  • · The options vest in five equal installments contingent on VWAP thresholds: $7.65, $10.20, $12.75, $15.30, and $17.85.
  • · The Reporting Person has not been convicted in any criminal proceeding or been party to any securities-related civil proceeding in the last five years.
  • · The filing is an amendment (Schedule 13D/A) to a prior beneficial ownership report.
BERKLEY W R CORP SC 13D/A neutral materiality 7/10

21-07-2026

This Schedule 13D/A filing by the Berkley family and related entities (the Reporting Persons) discloses beneficial ownership of 95,557,324 shares of W. R. Berkley Corporation common stock, representing 25.67% of outstanding shares as of April 27, 2026. The filing also notes that MS&AD Insurance Group Holdings and Mitsui Sumitomo Insurance Co., Ltd. (MSI) beneficially own an additional 58,780,450 shares (15.8%) as of June 4, 2026, and that under a Framework Agreement and LLC Agreement the Reporting Persons may be deemed to share voting power over those MSI shares, though they disclaim group status with MSI.

  • · The filing is Amendment No. 2 to Schedule 13D, originally filed May 1, 2026.
  • · The Reporting Persons disclaim forming a 'group' with MSI under Rule 13d-5(b)(1).
  • · The Framework Agreement was incorporated by reference from the Issuer's Form 8-K filed March 28, 2025.
  • · The Amended and Restated LLC Agreement among Symphony Partners, LLC, MSI, and WR Berkley & Others LLC was dated March 4, 2026.
ServiceTitan, Inc. SC 13G/A neutral materiality 4/10

21-07-2026

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G/A with the SEC on July 21, 2026, disclosing beneficial ownership of 3,149,920 shares of ServiceTitan, Inc. Class A Common Stock. This stake represents 3.8% of the outstanding shares as of June 30, 2026. The filing is an amendment to a previous 13G and indicates the group is a passive investor, not seeking to change or influence control of the company.

  • · The filing is an amendment (Schedule 13G/A) to a prior 13G filing.
  • · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers.
  • · The filing includes a Joint Filing Agreement dated July 20, 2026, among the reporting persons.
  • · The filers certify the securities were not acquired to change or influence control of the issuer.
Butterfly Network, Inc. SC 13D/A neutral materiality 5/10

21-07-2026

Jonathan M. Rothberg, founder and beneficial owner of Butterfly Network, Inc., filed Amendment No. 11 to Schedule 13D disclosing the sale of 3,126,453 shares of Class B common stock (automatically converted to Class A on a one-to-one basis) over July 17-21, 2026, at weighted average prices between $6.5959 and $6.7359 per share. The sales were executed for estate planning purposes under a Rule 10b5-1 trading plan adopted on March 13, 2026. Following these transactions, Rothberg and related entities continue to hold 22,086,850 shares of Class B common stock (100% of the Class B outstanding) and 828,775 shares of Class A common stock (0.4% of Class A outstanding).

  • · The sales were conducted for estate planning purposes under a Rule 10b5-1 trading plan entered into on March 13, 2026.
  • · Class B common stock automatically converted into Class A common stock on a one-to-one basis upon each sale.
  • · Rothberg's spouse holds 726,696 shares of Class A common stock included in the beneficial ownership calculation.
  • · 4C Holdings V, LLC is the largest holder of Class B common stock among the reporting entities, with 8,845,238 shares (40.0% of Class B outstanding).
  • · Rothberg directly holds 80,434 shares of Class A common stock and options to purchase 21,645 additional shares exercisable within 60 days.
AGI Inc SC 13G/A neutral materiality 6/10

21-07-2026

Lumina Capital Management Ltda. and its associated funds (the 'Lumina Funds') disclosed in an amended Schedule 13G filing with the SEC that they collectively own 11,130,936 Class A common shares of AGI Inc (AGBK), representing an 18.96% stake as of June 30, 2026. The largest holding among the group is by LCM Bigbang Fundo de Investimento, which alone owns 8,045,726 shares (13.71%), while Lumina Capital itself reports zero direct share ownership but may be deemed to share voting and dispositive power over the funds' holdings. No prior period comparison or change in ownership was provided in this filing.

  • · The filing is an amendment (No. 1) to a Schedule 13G, originally filed under Rule 13d-1(d).
  • · Lumina Capital Management serves as investment manager for all the Lumina Funds and may be deemed to share voting and dispositive power over their shares.
  • · Each Reporting Person disclaims beneficial ownership except for their pecuniary interest.
  • · Percentage calculations are based on 58,700,711 Class A common shares outstanding as of December 31, 2025, as reported in AGI's annual report on Form 20-F filed April 30, 2026.
  • · The filing includes a Joint Filing Agreement (Exhibit A) executed by all Reporting Persons.
SuperX AI Technology Ltd SC 13G neutral materiality 6/10

21-07-2026

Mercuria Holdings (Singapore) Pte. Ltd. filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 3,300,000 ordinary shares of SuperX AI Technology Ltd, representing a 7.1% stake. The filing is made under Rule 13d-1(c) and certifies that the shares were not acquired for the purpose of changing or influencing control of the issuer.

  • · The filing is a Schedule 13G (passive investment) under Rule 13d-1(c), not a 13D (activist filing).
  • · Mercuria Holdings has sole voting power and sole dispositive power over all 3,300,000 shares.
  • · SuperX AI Technology Ltd was formerly known as Super X AI Technology Ltd (name change on June 2, 2025) and Junee Ltd (name change on December 2, 2021).
  • · The company is incorporated in the D8 jurisdiction (likely Delaware) and has its business address in Singapore.
iPower Inc. SC 13G neutral materiality 3/10

21-07-2026

Dror Moshe Sherman filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 9,963 shares of iPower Inc. common stock, representing approximately 0.5% of outstanding shares. On July 14, 2026, Sherman acquired 100,000 shares (about 5.3% of outstanding) but subsequently disposed of 90,037 shares, resulting in a net position of only 9,963 shares. The filing indicates a rapid reduction in stake from a significant position to a minimal one, suggesting a trading rather than a long-term investment intent.

  • · The filing is made under Rule 13d-1(c), indicating the shares were not acquired to change or influence control of the issuer.
  • · Sherman is a citizen of both the United States and Israel.
  • · The issuer's most recent share count (1,891,147) was reported in a Form S-1 filed on July 10, 2026.
RYVYL Inc. SC 13G neutral materiality 6/10

21-07-2026

Jason Christopher Dorsett filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 4,174,028 shares of common stock in RTB Digital, Inc. (formerly RYVYL Inc.), representing 30.64% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

  • · The filing is a Schedule 13G (not 13D), indicating passive investment intent.
  • · Dorsett's sole voting and dispositive power covers all 4,174,028 shares.
  • · The issuer's SEC file number is 005-91720 and the CUSIP is 39366L406.
  • · Dorsett's business address is in San Juan, Puerto Rico.
Health Catalyst, Inc. SC 13G neutral materiality 5/10

21-07-2026

Impax Asset Management Group plc filed a Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 4,000,000 shares of Health Catalyst, Inc. common stock, representing 5.41% of the outstanding shares. The filing is made under Rule 13d-1(b) and indicates the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. Impax Asset Management LLC, a wholly owned subsidiary, retains investment discretion and control over the shares.

  • · The filing is a Schedule 13G (passive investment) rather than a 13D (activist filing), indicating the stake is not intended to influence control.
  • · Impax Asset Management LLC, the investment manager, retains sole voting and dispositive power over all 4,000,000 shares.
  • · The filing date is July 21, 2026, with the date of event (ownership as of) June 30, 2026.
Plum Acquisition Corp, IV SC 13G neutral materiality 3/10

21-07-2026

Context Capital Management, LLC and related parties filed a Schedule 13G disclosing beneficial ownership of 597,999 Class A ordinary shares of Plum Acquisition Corp, IV, representing 5.6% of the 10,702,490 shares outstanding as of July 9, 2026. The filing is a passive investment disclosure under Rule 13d-1(c) and does not indicate any change in control intent.

  • · The filing is made under Rule 13d-1(c) indicating passive investment intent.
  • · The reporting persons disclaim membership in a group and beneficial ownership except for pecuniary interest.
  • · Context Capital Management is the general partner and investment adviser of Context Partners Master Fund, L.P.
  • · The filing date is July 21, 2026, with the event date of beneficial ownership change on July 16, 2026.
Apyx Medical Corp SC 13G/A neutral materiality 5/10

21-07-2026

Royce & Associates LP filed an amended Schedule 13G with the SEC on July 21, 2026, reporting beneficial ownership of 3,274,064 shares of Apyx Medical Corp common stock as of June 30, 2026. This stake represents 7.81% of the outstanding shares, up from a prior position that was not disclosed in this filing. The filing indicates that Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, holds the shares in the ordinary course of business for investment management clients and disclaims any intent to change or influence control of the issuer.

  • · Royce & Associates LP is an investment adviser registered under the Investment Advisers Act of 1940.
  • · The shares are held for the benefit of registered investment companies and other managed accounts that are clients of Royce & Associates.
  • · Royce & Associates disclaims any pecuniary interest in the reported securities.
  • · The filing is made pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934.
  • · Royce & Associates reports sole voting power and sole dispositive power over all 3,274,064 shares.
CPI AEROSTRUCTURES INC SC 13G neutral materiality 5/10

21-07-2026

Royce & Associates LP disclosed a 6.33% beneficial ownership stake in CPI Aerostructures Inc. as of June 30, 2026, holding 835,632 shares of common stock. The filing, made under Rule 13d-1(d), indicates the shares are held in the ordinary course of business for investment management clients, with no intent to change or influence control of the issuer.

  • · The filing is a Schedule 13G, indicating passive investment intent (not an activist filing).
  • · Royce & Associates LP is an indirect majority-owned subsidiary of Franklin Resources Inc.
  • · Royce & Associates LP disclaims any pecuniary interest in the reported securities.
  • · The filing includes a detailed explanation of informational barriers between Royce and other Franklin Resources affiliates to avoid attribution of beneficial ownership.
EVI INDUSTRIES, INC. SC 13G/A neutral materiality 3/10

21-07-2026

Royce & Associates LP filed an amended Schedule 13G with the SEC on July 21, 2026, disclosing beneficial ownership of 703,990 shares of EVI Industries, Inc. common stock, representing a 5.47% stake as of June 30, 2026. The filing indicates no change in ownership from the prior period, with the same number of shares and percentage reported. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, Inc., disclaims any pecuniary interest and states the shares were acquired in the ordinary course of business, not for control purposes.

  • · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(d) of the Securities Exchange Act of 1934.
  • · Royce & Associates LP disclaims any pecuniary interest in the reported securities.
  • · The filing states that Royce & Associates exercises voting and investment powers independently from FRI affiliates, with informational barriers in place.
  • · The filing explicitly disclaims that Royce & Associates is part of a 'group' with FRI affiliates or principal shareholders for beneficial ownership purposes.
Manulife Private Credit Plus Fund SC 13D/A neutral materiality 5/10

21-07-2026

John Hancock Stable Value Fund Collective Investment Trust, through its trustee Global Trust Company, disclosed a 25% beneficial ownership stake in Manulife Private Credit Plus Fund as of June 30, 2026, holding 2,976,794 Class I common shares. The filing is an amendment (SC 13D/A) reflecting the Trust's investment of $6 million of its assets into the Fund. No negative or flat performance metrics are present in this ownership disclosure.

  • · The filing is an amendment to Schedule 13D (SC 13D/A), filed on July 21, 2026.
  • · The beneficial ownership is based on the May 30, 2026 NAV of the Fund.
  • · Global Trust Company, as trustee, has the right to vote and grant proxies on all investments held by the Trust.
  • · The Trust is organized in Maine, U.S., and Global Trust Company is also organized in Maine.

Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 29 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Activist Hedge Fund Institutional SEC 13D 13G

🇺🇸 More from United States

View all →